MR-Guided High Intensity Focused Ultrasound for Pain Management Of Osteoid Osteoma & Benign Bone Tumors in Children and Adults

NCT02618369 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-05-03

No results posted yet for this study

Summary

The Philips Sonalleve HIFU system is expected to be efficacious in reducing pain scores in patients with painful osteoid osteoma and other benign bone tumors, and in reducing their pain medication usage. No serious adverse effects are expected to result from this treatment.

Conditions

  • Osteoid Osteoma
  • Benign Bone Tumor
  • Pain

Interventions

DEVICE

MR-Guided High Intensity Focused Ultrasound

Target treatment of bone lesion using High Intensity Focused Ultrasound

Sponsors & Collaborators

  • Sunnybrook Health Sciences Centre

    collaborator OTHER
  • The Hospital for Sick Children

    lead OTHER

Principal Investigators

  • James M Drake, FRCSC, FACS · The Hospital for Sick Children

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2018-04-30
Completion
2018-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02618369 on ClinicalTrials.gov